Ushiyama S et al. |
RS-5186, a novel thromboxane synthetase inhibitor with a potent and extended duration of action. |
1988 |
Thromb. Res. |
pmid:3175990
|
Kosaki G et al. |
The mechanism of the inhibitory effect of protease inhibitors on platelet aggregation and cellular synthesis of prostaglandins. I. The effect on the release of arachidonic acid from phospholipids. |
1980 Dec 1-15 |
Thromb. Res. |
pmid:6785893
|
Rostagno C et al. |
In vitro effects of two novel calcium antagonists (nitrendipine and nisoldipine) on intraplatelet calcium redistribution, platelet aggregation and thromboxane A2 formation. Comparison with diltiazem, nifedipine and verapamil. |
1991 |
Thromb. Res. |
pmid:1754998
|
Catella F and FitzGerald GA |
Paired analysis of urinary thromboxane B2 metabolites in humans. |
1987 |
Thromb. Res. |
pmid:3686481
|
Kohda N et al. |
Effect of cilostazol, a phosphodiesterase III inhibitor, on experimental thrombosis in the porcine carotid artery. |
1999 |
Thromb. Res. |
pmid:10593428
|
Davì G et al. |
Inhibition of platelet function by ticlopidine in arteriosclerosis obliterans of the lower limbs. |
1985 |
Thromb. Res. |
pmid:2933846
|
Takasaki W et al. |
Enzyme immunoassay of human plasma 11-dehydrothromboxane B2. |
1991 |
Thromb. Res. |
pmid:1957275
|
Riess H et al. |
Thromboxane receptor blockade versus cyclooxigenase inhibition: antiplatelet effects in patients. |
1986 |
Thromb. Res. |
pmid:3012819
|
Pirich C et al. |
Effects of fish oil supplementation on platelet survival and ex vivo platelet function in hypercholesterolemic patients. |
1999 |
Thromb. Res. |
pmid:10588465
|
Altman R et al. |
Synergistic actions of PAF-acether and sodium arachidonate in human platelet aggregation. 1. Studies in normal human platelet rich plasma. |
1986 |
Thromb. Res. |
pmid:3014677
|
Yamaguchi A et al. |
Effect of cetiedil on platelet aggregation and thromboxane synthesis. |
1985 |
Thromb. Res. |
pmid:2986312
|
Lukaszyk A et al. |
Does acute experimental pancreatitis affect blood platelet function? |
1989 |
Thromb. Res. |
pmid:2524119
|
Swart SS et al. |
Functional significance of the platelet alpha2-adrenoceptor: studies in patients with myeloproliferative disorders. |
1984 |
Thromb. Res. |
pmid:6326344
|
Alessandrini P et al. |
Physiologic variables affecting thromboxane B2 production in human whole blood. |
1985 |
Thromb. Res. |
pmid:3983893
|
Best LC et al. |
The interrelationship between thromboxane biosynthesis, aggregation and 5-hydroxytryptamine secretion in human platelets in vitro. |
1980 |
Thromb. Haemost. |
pmid:6773171
|
Han P et al. |
Inhibition of platelet function of antiarrhythmic drugs, verapamil and disopyramide. |
1982 |
Thromb. Haemost. |
pmid:7101234
|
Greer IA et al. |
A comparative study of the effects of adrenoceptor antagonists on platelet aggregation and thromboxane generation. |
1985 |
Thromb. Haemost. |
pmid:2867620
|
Miller KW and Keith JC |
Effect of thromboxane synthetase inhibition on platelet function and morphology during ovine pregnancy-induced hypertension. |
1988 |
Thromb. Haemost. |
pmid:3238644
|
Teng CM et al. |
ADP-mimicking platelet aggregation caused by rugosin E, an ellagitannin isolated from Rosa rugosa Thunb. |
1997 |
Thromb. Haemost. |
pmid:9066010
|
Joseph S et al. |
Effect of the polyamine-spermine on agonist-induced human platelet activation--specific inhibition of "aggregation-independent" events induced by thrombin, but not by collagen, thromboxane mimetic, phorbol ester or calcium ionophore. |
1987 |
Thromb. Haemost. |
pmid:3110996
|
Pampolina C and McNicol A |
Streptococcus sanguis-induced platelet activation involves two waves of tyrosine phosphorylation mediated by FcgammaRIIA and alphaIIbbeta3. |
2005 |
Thromb. Haemost. |
pmid:15886812
|
Jilma-Stohlawetz P et al. |
Impaired platelet function among platelet donors. |
2001 |
Thromb. Haemost. |
pmid:11583322
|
Dejana E et al. |
Bleeding time in rats: a comparison of different experimental conditions. |
1982 |
Thromb. Haemost. |
pmid:6753230
|
Strano A et al. |
Platelet sensitivity to prostacyclin and thromboxane production in hyperlipidemic patients. |
1982 |
Thromb. Haemost. |
pmid:6753232
|
Swartz SL and Moore TJ |
Effect of angiotensin II on collagen-induced platelet activation in normotensive subjects. |
1990 |
Thromb. Haemost. |
pmid:2339363
|
Siess W et al. |
Stimulated platelet aggregation, thromboxane B2 formation and platelet sensitivity to prostacyclin - a critical evaluation. |
1981 |
Thromb. Haemost. |
pmid:7025338
|
Watanabe J et al. |
Effect of vitamin E on platelet aggregation in diabetes mellitus. |
1984 |
Thromb. Haemost. |
pmid:6495252
|
Carter AJ et al. |
A comparison of human pulmonary arterial and venous prostacyclin and thromboxane synthesis--effect of a thromboxane synthase inhibitor. |
1984 |
Thromb. Haemost. |
pmid:6377567
|
Spectre G et al. |
Twice daily dosing of aspirin improves platelet inhibition in whole blood in patients with type 2 diabetes mellitus and micro- or macrovascular complications. |
2011 |
Thromb. Haemost. |
pmid:21800009
|
Kyrle PA et al. |
Investigation of the interaction of blood platelets with the coagulation system at the site of plug formation in vivo in man--effect of low-dose aspirin. |
1987 |
Thromb. Haemost. |
pmid:2954260
|
Gresele P et al. |
Picotamide protects mice from death in a pulmonary embolism model by a mechanism independent from thromboxane suppression. |
1990 |
Thromb. Haemost. |
pmid:2274931
|
Krishnamurthi S et al. |
Effect of pyridoxal 5'-phosphate (PALP) on human platelet aggregation, dense granule release and thromboxane B2 generation--role of Schiff base formation. |
1982 |
Thromb. Haemost. |
pmid:6891107
|
Essien EM et al. |
Blood changes and enhanced thromboxane and 6-keto prostaglandin F1 alpha production in experimental acute Plasmodium bergei infection in hamsters. |
1984 |
Thromb. Haemost. |
pmid:6388013
|
Chen SL et al. |
Chlorobutanol, a preservative of desmopressin, inhibits human platelet aggregation and release in vitro. |
1990 |
Thromb. Haemost. |
pmid:2096493
|
Martinuzzo ME et al. |
Antiphospholipid antibodies enhance thrombin-induced platelet activation and thromboxane formation. |
1993 |
Thromb. Haemost. |
pmid:8115993
|
Stratta P et al. |
Warning: platelet factor 4, beta-thromboglobulin and thromboxane in donor's plasma units. |
1983 |
Thromb. Haemost. |
pmid:6189235
|
Larson MK et al. |
Effects of omega-3 acid ethyl esters and aspirin, alone and in combination, on platelet function in healthy subjects. |
2008 |
Thromb. Haemost. |
pmid:18841286
|
Hoet B et al. |
Ridogrel, a combined thromboxane synthase inhibitor and receptor blocker, decreases elevated plasma beta-thromboglobulin levels in patients with documented peripheral arterial disease. |
1990 |
Thromb. Haemost. |
pmid:2148849
|
Cattaneo M et al. |
Human platelet aggregation and release reaction induced by platelet activating factor (PAF-acether)--effects of acetylsalicylic acid and external ionized calcium. |
1985 |
Thromb. Haemost. |
pmid:3927505
|
Wang WJ and Huang TF |
A novel tetrameric venom protein, agglucetin from Agkistrodon acutus, acts as a glycoprotein Ib agonist. |
2001 |
Thromb. Haemost. |
pmid:11686327
|
Davì G et al. |
Increased thromboxane metabolites excretion in liver cirrhosis. |
1998 |
Thromb. Haemost. |
pmid:9569186
|
Sheu JR et al. |
Mechanisms involved in the antiplatelet activity of Staphylococcus aureus lipoteichoic acid in human platelets. |
2000 |
Thromb. Haemost. |
pmid:10823277
|
Crescente M et al. |
Gallic acid, a dietary polyphenolic component, blunts the inhibition of platelet COX-1 by aspirin: preliminary in-vitro findings. |
2007 |
Thromb. Haemost. |
pmid:17549313
|
Landolfi R et al. |
Effects of unfractionated and low molecular weight heparins on platelet thromboxane biosynthesis "in vivo". |
1994 |
Thromb. Haemost. |
pmid:7740468
|
Undas A et al. |
Lack of aspirin-induced decrease in thrombin formation in subjects resistant to aspirin. |
2007 |
Thromb. Haemost. |
pmid:17549314
|
Homoncik M et al. |
Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100. |
2000 |
Thromb. Haemost. |
pmid:10739392
|
Perneby C et al. |
Dose- and time-dependent antiplatelet effects of aspirin. |
2006 |
Thromb. Haemost. |
pmid:16601836
|
Eldor A et al. |
Effects of dipyrone on prostaglandin production by human platelets and cultured bovine aortic endothelial cells. |
1983 |
Thromb. Haemost. |
pmid:6346571
|
Menys VC and Davies JA |
Selective inhibition of thromboxane synthetase with dazoxiben - basis of its inhibitory effect on platelet adhesion. |
1983 |
Thromb. Haemost. |
pmid:6346575
|
Hampton KK et al. |
Coagulation, fibrinolytic and platelet function in patients on long-term therapy with aspirin 300 mg or 1,200 mg daily compared with placebo. |
1990 |
Thromb. Haemost. |
pmid:2073296
|
Vejar M et al. |
Dissociation of platelet activation and spontaneous myocardial ischemia in unstable angina. |
1990 |
Thromb. Haemost. |
pmid:2363117
|
Foo LC et al. |
Platelets of habitual smokers have reduced susceptibility to aggregating agent. |
1991 |
Thromb. Haemost. |
pmid:2048056
|
Dragani A et al. |
Oxidative stress and platelet activation in subjects with moderate hyperhomocysteinaemia due to MTHFR 677 C→T polymorphism. |
2012 |
Thromb. Haemost. |
pmid:22782530
|
Gordge MP et al. |
Platelet function and the bleeding time in progressive renal failure. |
1988 |
Thromb. Haemost. |
pmid:3187950
|
D'Angelo A et al. |
Effect of des-amino-D-arginine vasopressin (DDAVP) on plasma levels of platelet and endothelial cell release products. |
1983 |
Thromb. Haemost. |
pmid:6687766
|
Lessiani G et al. |
Inflammation, oxidative stress and platelet activation in aspirin-treated critical limb ischaemia: beneficial effects of iloprost. |
2011 |
Thromb. Haemost. |
pmid:21103664
|
Hohlfeld T et al. |
Antiplatelet effects of ticlopidine are reduced in experimental hypercholesterolemia. |
1994 |
Thromb. Haemost. |
pmid:7513092
|
Guthikonda S et al. |
Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy. |
2008 |
Thromb. Haemost. |
pmid:18612542
|
Naesh O et al. |
Platelet function in surgical stress. |
1985 |
Thromb. Haemost. |
pmid:2935969
|
Michelson AD et al. |
Reversible inhibition of human platelet activation by hypothermia in vivo and in vitro. |
1994 |
Thromb. Haemost. |
pmid:7522354
|
Dale J et al. |
The effect of a thromboxane synthetase inhibitor, dazoxiben, and acetylsalicylic acid on platelet function and prostaglandin metabolism. |
1983 |
Thromb. Haemost. |
pmid:6689091
|
Hornby EJ et al. |
The inhibitory effect of GR32191, a thromboxane receptor blocking drug, on human platelet aggregation, adhesion and secretion. |
1989 |
Thromb. Haemost. |
pmid:2529661
|
Bar J et al. |
The regulation of platelet aggregation in vitro by interleukin-1beta and tumor necrosis factor-alpha: changes in pregnancy and in pre-eclampsia. |
1997 |
Thromb. Haemost. |
pmid:9364994
|
Husted SE et al. |
Intravenous acetylsalicylic acid--dose-related effects on platelet function and fibrinolysis in healthy males. |
1992 |
Thromb. Haemost. |
pmid:1412171
|
Wang JS et al. |
Effect of strenuous arm exercise on oxidized-LDL-potentiated platelet activation in individuals with spinal cord injury. |
2000 |
Thromb. Haemost. |
pmid:10928481
|
Barrett PA and Butler KD |
Shortening of platelet survival by induced hypercholesterolaemia in rabbits and its prolongation by anagrelide. |
1983 |
Thromb. Haemost. |
pmid:6648889
|
Halawani SH et al. |
Aspirin failure in patients presenting with acute cerebrovascular ischaemia. |
2011 |
Thromb. Haemost. |
pmid:21544317
|
Connellan JM et al. |
Investigation of alternative mechanisms of collagen-induced platelet activation by using monoclonal antibodies to glycoprotein IIb-IIIa and fibrinogen. |
1986 |
Thromb. Haemost. |
pmid:2940722
|
Patrono C et al. |
Characterization of biochemical and functional effects of antiplatelet drugs as a key to their clinical development. |
1995 |
Thromb. Haemost. |
pmid:8578493
|
Cortellaro M et al. |
Transcoronary platelet thromboxane A2 formation without platelet trapping in patients with coronary stenosis-effect of sulphinpyrazone treatment. |
1983 |
Thromb. Haemost. |
pmid:6665767
|
Szczeklik A et al. |
Prolonged bleeding time, reduced platelet aggregation, altered PAF-acether sensitivity and increased platelet mass are a trait of asthma and hay fever. |
1986 |
Thromb. Haemost. |
pmid:3563961
|
Larsen SB et al. |
Increased platelet aggregation and serum thromboxane levels in aspirin-treated patients with prior myocardial infarction. |
2012 |
Thromb. Haemost. |
pmid:22534977
|
Fruzzetti F et al. |
Platelet-vessel wall interactions with third-generation oral contraceptives: no evidence of detrimental effects. |
1999 |
Thromb. Haemost. |
pmid:10494782
|
Cattaneo M et al. |
Conditions influencing the interaction of asialo von Willebrand factor with human platelets--the effects of external ionized calcium concentration and the role of arachidonate pathway. |
1988 |
Thromb. Haemost. |
pmid:3146144
|
Fimognari FL et al. |
Nocturnal rise of urinary thromboxane B 2 in patients with coronary artery disease. |
2005 |
Thromb. Haemost. |
pmid:15735822
|
De Caterina R et al. |
Organic nitrates: direct antiplatelet effects and synergism with prostacyclin. Antiplatelet effects of organic nitrates. |
1988 |
Thromb. Haemost. |
pmid:3291182
|
Teng CM and Ko FN |
Comparison of the platelet aggregation induced by three thrombin-like enzymes of snake venoms and thrombin. |
1988 |
Thromb. Haemost. |
pmid:3291184
|
de Castellarnau C et al. |
Prostacyclin and thromboxane production by autogenous femoral veins grafted into the arterial circulation of the dog. |
1989 |
Thromb. Haemost. |
pmid:2665174
|
Zahavi J and Zahavi M |
Enhanced platelet release reaction, shortened platelet survival time and increased platelet aggregation and plasma thromboxane B2 in chronic obstructive arterial disease. |
1985 |
Thromb. Haemost. |
pmid:3158092
|
Etulain J et al. |
Acidosis downregulates platelet haemostatic functions and promotes neutrophil proinflammatory responses mediated by platelets. |
2012 |
Thromb. Haemost. |
pmid:22159527
|
Rocca B et al. |
Increased thromboxane biosynthesis in essential thrombocythemia. |
1995 |
Thromb. Haemost. |
pmid:8607099
|
Pettinella C et al. |
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin. |
2009 |
Thromb. Haemost. |
pmid:19350112
|
Totani L et al. |
Prasugrel inhibits platelet-leukocyte interaction and reduces inflammatory markers in a model of endotoxic shock in the mouse. |
2012 |
Thromb. Haemost. |
pmid:22436970
|
Véricel E et al. |
Moderate oral supplementation with docosahexaenoic acid improves platelet function and oxidative stress in type 2 diabetic patients. |
2015 |
Thromb. Haemost. |
pmid:25832443
|
Kyrle PA et al. |
Evidence for an increased generation of prostacyclin in the microvasculature and an impairment of the platelet alpha-granule release in chronic renal failure. |
1988 |
Thromb. Haemost. |
pmid:2975407
|
Spowart K et al. |
Haemostatic effects of ketorolac with and without concomitant heparin in normal volunteers. |
1988 |
Thromb. Haemost. |
pmid:3266379
|
Cerletti C et al. |
Aspirin kinetics and inhibition of platelet thromboxane generation-relevance for a solution of the "aspirin dilemma". |
1985 |
Thromb. Haemost. |
pmid:4049312
|
Hillbom M et al. |
Platelet thromboxane formation and bleeding time is influenced by ethanol withdrawal but not by cigarette smoking. |
1985 |
Thromb. Haemost. |
pmid:4049313
|
Aoki T et al. |
Difference of (Ca2+)i movements in platelets stimulated by thrombin and TRAP: the involvement of alpha(IIb)beta3-mediated TXA2 synthesis. |
1998 |
Thromb. Haemost. |
pmid:9657446
|
McMahon GS et al. |
Transient heparin-induced platelet activation linked to generation of platelet 12-lipoxygenase. Findings from a randomised controlled trial. |
2013 |
Thromb. Haemost. |
pmid:23494053
|
Larsen SB et al. |
Reduced antiplatelet effect of aspirin is associated with low-grade inflammation in patients with coronary artery disease. |
2013 |
Thromb. Haemost. |
pmid:23407706
|
Dotevall A et al. |
Cigarette smoking increases thromboxane A2 formation without affecting platelet survival in young healthy females. |
1992 |
Thromb. Haemost. |
pmid:1455405
|
De Caterina R et al. |
Benefit/risk profile of combined antiplatelet therapy with ticlopidine and aspirin. |
1991 |
Thromb. Haemost. |
pmid:1871711
|
de Boer A et al. |
Interaction study between Org 10172, a low molecular weight heparinoid, and acetylsalicylic acid in healthy male volunteers. |
1991 |
Thromb. Haemost. |
pmid:1722918
|
Blais N et al. |
Response to aspirin in healthy individuals. Cross-comparison of light transmission aggregometry, VerifyNow system, platelet count drop, thromboelastography (TEG) and urinary 11-dehydrothromboxane B(2). |
2009 |
Thromb. Haemost. |
pmid:19652893
|
Forastiero R et al. |
Anti-beta2 glycoprotein I antibodies and platelet activation in patients with antiphospholipid antibodies: association with increased excretion of platelet-derived thromboxane urinary metabolites. |
1998 |
Thromb. Haemost. |
pmid:9459320
|
Holme S et al. |
The effect of albumin bound polyunsaturated fatty acids on human platelets. |
1984 |
Thromb. Haemost. |
pmid:6719386
|
Carter AJ and Hanley SP |
The effect of platelet number and haematocrit on whole blood thromboxane synthesis. |
1985 |
Thromb. Haemost. |
pmid:4024033
|
Brox JH et al. |
The effect of cod liver oil and corn oil on platelets and vessel wall in man. |
1981 |
Thromb. Haemost. |
pmid:7031981
|
Strano A et al. |
Thromboxane formation by platelets and platelet sensitivity to prostacyclin in patients with acute myocardial infarction. |
1981 |
Thromb. Haemost. |
pmid:7036402
|